Precision Neuroscience
Precision Neuroscience is a brain-computer interface company developing minimally invasive, implantable neural technology, including its flagship Layer 7 Cortical Interface, to read and interpret brain signals and help patients affected by neurological conditions such as paralysis.
Analytics date: 03.11.2026
Basic information
Head office
54 West 21st Street, Suite 310, New York, NY 10010, United StatesHead officeGeography of business
United States of AmericaGeography of businessDate of the last round
Last round 09/2026Date of the last roundTotal funds raised
$429.1M+Total funds raisedPrice per share
$8.10Price per sharePrice per share. Based on the latest known transaction. It is not an offer or investment recommendation.
Analytics date: 03.11.2026
Financial indicators
0 0 0000
00000 0000 000 00 0 0000000 00 0 00000000000000000000
0000
00 0 000 0 0 000 0 0000 0000000000000000000000000000000000000000000000000000000000000000000000000000000000000
00 00000
000 00 0 0 000 0 00 00 0000 0000 00 0 0 000 00 0 00 0 0 0 000000000000000000000000000000000000000000000000000000000000000000000000000000
000 0 000
0 00 00 0 00 0 0 0 0 00 000 0000 00 00 0 0 0000000000000000000000000000000000000000000000000000000000
0 0000000
0 00 000 0 000 0 0000 00 0 00 0 000 0 0000 000 0 0 0000 000 0000000000000000000000000000000000000000000000000000000000000
0000
0 0 0 0 0 0 0 0 00 00 00 0 0 00000000 0 000 0 00 00 00 0 000000 0000 0 0 000 0000000000000000000000000000000
000000 0000000 00000 0000 000000000 00000 00000000 0000000 000000000 000000000000 0000000 000000000 00000 000 00000000 000 0000 0000000000000 00000000 00 00000 000000 00000 00000000000 000000 000000000 00000000 00000 000000 000 00000 00000 00000000 0000000 00000 00000 0000000000 000 00000 00000000000 0 000 0000 00000000000 00000000 0000000 00000 000000 00000 00000000 00000 00000000000 0000 0000000 00000 0000 0000000
00000 00000 00000 000 00000 00000000000 00000000000 00000 00000 0000000000 00000000000 00000 0000 0000 00000000 0000000 000000000 000 000 00000 0000 0000000 0000000 00000000000 0000000000 00000000000 0000000000 0000000000 00000000 00000 00000000 000000 000000 00000 0000 000 0000000 0000000 00000000000 000000000 00000000 00000000000 00000000000 000000 00000000 00000000 00000 0000000000 0000000 000 00000000000000 000000 0000000 0000 000000 000 0000 00000 000000000 0000 0000000 000 000000 00000000 0000000000000 00000 000000000000000
0000000 00 000000000 0000000000 000 00000 0000000000 00000000 000 0000000000 0000000 00000000 00000000000 0000000000 0000000 00000 000 00000 0000 00000 000 0000 0000000 000000 0000 00000 000000 000000 0000000 00000 0000
000000000 00000 00000000 0000000 000000000 000000000000 0000000 000000000 00000 000 00000000 000 0000 0000000000000 00000000 00 00000 000000 00000 00000000000 000000 000000000 00000000 00000 000000 000 00000 00000 00000000 0000000 00000 00000 0000000000 000 00000 00000000000 0 000 0000 00000000000 00000000 000 0000 000000 00000 0000 000000000 000000000000 000 00000000 0000000 00000 000000000 00 0000000 000000 00000000 000000000 000000 000000 0000000000 00000 000000000000 00000000 00000 00000 00000 0000 000 0000000000 000000000000 000000 0000000000 0000 00000000000000 00000000 00000000 000 00 000000000
Request price
Key financial indicators
| Revenue |
| Employees | |
| 000 000 | ... |
| 0000 | ... |
| Customers | |
| 00000000 | ... |
| 0 0 000000 | ... |
Competitor Analysis
Comparison to other companies in the industry.
| Name | Evaluation |
| Private companies | |
Neuralink | $ 59.1B |
Merge Labs | $ 850M |
Isomorphic Labs | ... |
NaturalCycles | ... |
Flo Health | $ 1B |
| Traded companies | |
NeuroMetrix | ... |
NeuroPace | $ 423.6M |
Recursion Pharmaceuticals | $ 2.3B |
Schrödinger | $ 2B |
Relay Therapeutics | $ 3.8B |